Enhanced Antipsychotic Treatment: Modulating Oxidative Stress with Vitamin D and E Co-Administration
DOI:
https://doi.org/10.36283/ziun-pjmd13-4/012Keywords:
Vitamins, Glutathione Peroxidase GPX1, Superoxide DismutaseAbstract
Background: Antipsychotics may increase oxidative stress, potentially damaging brain tissues. Antioxidants like vitamins D and E could mitigate this side effect from long-term antipsychotic use. This study aimed to assess the effect of vitamin D & E by measuring two oxidative markers, Superoxide Dismutase and Glutathione Peroxidase, in patients undergoing antipsychotic treatment.
Methods: A randomized controlled trial (NCT 06200584), approved by the ERB, was conducted from January to June 2021 at the Baluchistan Institute of Psychiatry and Behavioral Sciences, Quetta, Pakistan. Using non-probability purposive sampling, 260 participants were enrolled. Group 1 served as healthy controls, while groups 2, 3, and 4 received olanzapine (10 mg/day), risperidone (2 mg/day), and quetiapine (100 mg/day), respectively. Groups 5, 6, and 7 received the same antipsychotics with added vitamin D (200,000 IU weekly) and vitamin E (400 mg daily). After two months, blood samples were analyzed for SOD and GPx, with statistical analysis performed using SPSS 26. Independent samples t-test and ANOVA were applied, p-value≤0.05 was considered significant.
Results: Compared to control, statistically significantly lower enzyme levels were observed in Groups 2 and 3 (p<0.001roups 5, 6 and 7 with Vitamin E and D along with one of the antipsychotics, had significantly raised blood enzyme levels (p < 0.001) vs control. No gender-based differences were observed between the groups.
Conclusion: Antipsychotics cause redox imbalance with decreases in oxidative markers whereas antioxidants, vitamins D and E can significantly increase these enzymes and thus can be a valuable addition in management to lower oxidative stress in psychotic patients.
References
Dworzański J, Strycharz-Dudziak M, Kliszczewska E, Kiełczykowska M, Dworzańska A, et al. Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity in patients with diabetes mellitus type 2 infected with Epstein-Barr virus. Plos one. 2020;15(3): e0230374. DOI https://doi.org/10.1371/journal.pone.0230374
Hristova M, Penev M. Oxidative stress and cardiovascular diseases. Trakia Journal of Sciences. 2014;12(3): 296-303.DOI: doi:10.15547/tjs.2014.03.012
Bayliak MM, Gospodaryov DV, Lushchak VI. Homeostasis of carbohydrates and reactive oxygen species is critically changed in the brain of middle-aged mice: Molecular mechanisms and functional reasons. BBA advances. 2023 :100077. DOI: https://doi.org/10.1016/j.bbadva.2023.100077.
Demirci-Çekiç S, Özkan G, Avan AN, Uzunboy S, Çapanoğlu E, Apak R et al. Biomarkers of oxidative stress and antioxidant defense. Journal of pharmaceutical and biomedical analysis. 2022; 209:114477. DOI: https://doi.org/10.1016/j.jpba.2021.114477.
Ballance WC, Qin EC, Chung HJ, Gillette MU, Kong H et al. Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. Biomaterials. 2019; 217:119292. DOI: https://doi.org/10.1016/j.biomaterials.2019.119292.
Qian F, Han Y, Han Z, Zhang D, Zhang L et al. In Situ implantable, post-trauma microenvironment-responsive, ROS Depletion Hydrogels for the treatment of Traumatic brain injury. Biomaterials. 2021; 270:120675. DOI: https://doi.org/10.1016/j.biomaterials.2021.120675.
Majeed M, Shakoori TA, Abid S, Shahzad N, Niazi Z, et al. Oxidative Stress and Decreased Serum Levels of Superoxide Dismutase (SOD) as a Potent Risk Factor for Thyroid Disease among Local Pregnant Females in Punjab. Pakistan Journal of Medicine and Health Sciences 2023; 17(5):146-149. DOI: https://doi.org/10.53350/pjmhs2023175146
Holick MF, Mazzei L, García Menéndez S, Martín Giménez VM, Al Anouti F, et al. Genomic or Non-Genomic? A Question about the Pleiotropic Roles of Vitamin D in Inflammatory-Based Diseases. Nutrients. 2023 ;15(3):767. DOI: https://doi.org/10.3390/nu15030767
Zhang X, Wu S, Guo C, Guo K, Hu Z, Peng J et al. Vitamin E exerts neuroprotective effects in pentylenetetrazole kindling epilepsy via suppression of ferroptosis. Neurochemical Research. 2022; 1:1-9. DOI: https://doi.org/10.1007/s11064-021-03483-y
Jena AB, Samal RR, Bhol NK, Duttaroy AK. Cellular Red-Ox system in health and disease: The latest update. Biomedicine & Pharmacotherapy. 2023; 162:114606. DOI: https://doi.org/10.1016/j.biopha.2023.114606
Zhang XY, Zhou DF, Cao LY, Xu CQ, Chen D et al. The Effect of Vitamin E Treatment on Tardive Dyskinesia and Blood Superoxide Dismutase: A Double-Blind Placebo-Controlled Trial. Journal of Clinical Psychopharmacology 2004; 24(1): 83-86. DOI: 10.1097/01.jcp.0000104912.75206.2b
Maier CM, Chan PH. Book review: role of superoxide dismutases in oxidative damage and neurodegenerative disorders. The Neuroscientist. 2002;8(4):323-34. DOI: https://doi.org/10.1177/107385840200800408
Djordjević VV, Kostić J, Krivokapić Ž, Krtinić D, Ranković M, Petković M, Ćosić V. Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase in Patients with Schizophrenia. Medicina (Kaumas). 2022;58(10):1491. DOI: 10.3390/medicina58101491
Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR, Smirnova LP. Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives. Oxidative Medicine and Cellular Longev. 2021; 2021:8881770. DOI: 10.1155/2021/8881770.
Parikh V, Khan MM, and Mahadik SP. Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Journal of Psychiatric Research 2003;37(1): 43–51 DOI: https://doi.org/10.1016/S0022-3956(02)00048-1
Padurariu MA, Dobrin CI and Stefanescu C. Evaluation of antioxidant enzymes activities and lipid peroxidationin schizophrenic patients treated with typical and atypical antipsychotics. Neuroscience Letters 2010; 479(3): 317–320. DOI: https://doi.org/10.1016/j.neulet.2010.05.088
Boškovic TM, Vovk B, Plesničar K and Grabnar I. Oxidative stress in schizophrenia. Current Neuropharmacology 2011; 9 (2); 301–312. DOI: https://doi.org/10.2174/157015911795596595
Fahira A, Zhu Z, Li Z, and Shi Y. Scrutinizing the causal relationship between schizophrenia and vitamin supplementation: a Mendelian randomization study. Journal of Bio-X Research 2022;5(1): 18-26. DOI :10.1097/JBR.0000000000000104
Zhu JL, Luo WW, Cheng X, Li Y, Zhang QZ et al. Vitamin D deficiency and Schizophrenia in Adults: A Systematic Review and Meta-analysis of Observational Studies. Psychiatry Research. 2020; 288:112959. DOI: 10.1016/j.psychres.2020.112959
Gaebler AJ, Finner-Prével M, Lammertz S, Schaffrath S, Eisner P et al. The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia. British Journal of Clinical Pharmacology. 2022 ;88(7):3193-3200. DOI: 10.1111/bcp.15223
Dopsaj V, Martinovic J, Dopsaj M, Stevuljevic JK, Bogavac-Stanojevic N. Gender-Specific Oxidative Stress Parameters. Int J Sports Med 2011; 32(1): 14-19. DOI: 10.1055/s-0030-1267930
Liu H, Liu H, Jiang S, Su L, Lu Y, Chen Z, et al. Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study. Curr Neuropharmacology20223;20(9): 1793-1803.DOI:10.2174/1570159X19666211111123918
Goldstein JM, Cohen LS, Horton NJ, Lee H, Andersen S, Tohen M et al. Sex differences in clinical response to olanzapine compared with haloperidol. Psychiatry Res. 2002;110(1):27–37. DOI: 10.1016/S0165-1781(02)00028-8
Wu JQ., Kosten TR., Zhang XY. Free radicals, antioxidant defense systems, and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2013; 46:200–206. DOI: 10.1016/j.pnpbp.2013.02.015
Smith S. Gender differences in antipsychotic prescribing. Int. Rev. Psychiatry. 2010;22(5):472–484. DOI: 10.3109/09540261.2010.515965.
Soldin OP, Chung SH, Mattison DR. Sex differences in drug disposition. J. Biomed. Biotechnol. 2011; 2011:187103. doi: 10.1155/2011/187103
Nisar M, Mohammad RM, Fatima S, Shaikh PR, Rehman M. Perceptions pertaining to clinical depression in Karachi, Pakistan. Cureus. 2019;11(7): e5094. DOI: 10.7759/cureus.5094
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
How to Cite
